Chardan Capital Comments on Anixa Biosciences, Inc.'s FY2024 Earnings (NASDAQ:ANIX)

Anixa Biosciences, Inc. (NASDAQ:ANIX – Get Rating) – Stock analysts at Chardan Capital issued their FY2024 EPS estimates for shares of Anixa Biosciences in a research note issued on Wednesday, March 22nd. Chardan Capital analyst M. Barcus forecasts that the company will post earnings per share of $4.61 for the year. Chardan Capital has a […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Anixa Biosciences ,Anixa Bioscience ,Cambridge Investment Research Advisors Inc ,Nasdaq ,Anixa Biosciences Company Profile ,Virtu Financial ,Anixa Biosciences Inc ,Nations Financial Group Inc ,International Assets Investment Management ,Us Bancorp ,Get Rating ,Chardan Capital ,Assets Investment Management ,Financial Group ,Cambridge Investment Research Advisors ,Cancer Vaccines ,Anti Viral Therapeutics ,Cancer Diagnostics ,Anixa Biosciences Daily ,Nasdaq Anix ,Sanix ,Medical ,Earnings Estimates ,